In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody

S Veronese1, M Gambacorta, B Falini

  • 1Istituto di Anatomia Patologica, Ospedale di Niguarda, Milan, Italy.

Insights

Detecting proliferating cells using bromodeoxyuridine (BrdU) requires specific tissue preparation. Bouin

Area of Science:

  • Histopathology
  • Cell Biology
  • Immunohistochemistry

Background:

  • Bromodeoxyuridine (BrdU) incorporation into DNA labels proliferating cells.
  • Immunohistochemistry is a common method for detecting BrdU.
  • Tissue fixation and DNA denaturation methods can affect BrdU detection.

Purpose of the Study:

  • To investigate the impact of various fixatives and DNA denaturation techniques on anti-BrdU antibody reactivity.
  • To determine optimal methods for in situ detection of BrdU-labeled cells.

Main Methods:

  • Human tissues were incubated in vitro with BrdU.
  • Immunohistochemical staining was performed using an anti-BrdU monoclonal antibody.
  • Different fixatives (Bouin's fluid, formalin) and DNA denaturation methods (pepsin digestion, acid, thermal) were tested.

Main Results:

  • Bouin's fluid fixation optimally preserved BrdU antigenicity in proliferating cells.
  • Formalin fixation resulted in poor BrdU reactivity, which could be partially restored by pepsin digestion but with morphological artifact.
  • Acid and thermal DNA denaturation techniques yielded comparable results.

Conclusions:

  • Bouin fixation is superior to formalin for preserving BrdU antigenicity.
  • Acid or thermal DNA denaturation is effective for detecting BrdU.
  • The recommended method for in situ detection of S-phase cells using anti-BrdU is Bouin fixation followed by DNA denaturation.

Related Concept Videos